Paul Austin on Microdosing and the Future of Psychedelics
podcasts.apple.comSaved by sari
Paul Austin on Microdosing and the Future of Psychedelics
Who among the first generation of psychedelic researchers would dispute a word of this classic gust of Leary exuberance, circa 1963: “Make no mistake: the effect of consciousness-expanding drugs will be to transform our concepts of human nature, of human potentialities, of existence. The game is about to be changed, ladies and gentlemen. Man is abo
... See moreMichael Pollan • How to Change Your Mind: What the New Science of Psychedelics Teaches Us About Consciousness, Dying, Addiction, Depression, and Transcendence
Of even keener interest to Bob Jesse was the early research exploring the potential of psychedelics to contribute to what, in a striking phrase, he calls “the betterment of well people.”
Michael Pollan • How to Change Your Mind: The New Science of Psychedelics
You need to be microdosing maxxing.
10 micrograms of LSD. Every 48 hours. For 6–8 weeks.
Not to “feel something” but to mitigate inflammation, rewire neurotic loops, and spike BDNF.
Skip this protocol and you’re leaving an insane amount of brainpower on the table.
10 micrograms of LSD. Every 48 hours. For 6–8 weeks.
Not to “feel something” but to mitigate inflammation, rewire neurotic loops, and spike BDNF.
Skip this protocol and you’re leaving an insane amount of brainpower on the table.
Paul F. Austin • Tweet
Specially trained psychiatrists and psychologists are now administering hallucinogens and other potent psychotropic agents (psilocybin, ketamine, ecstasy) as mental health remedies. Administering limited doses (one to three) of psychedelics interspersed with multiple sessions of talk therapy over many weeks has become the modern equivalent of shama
... See moreAnna Lembke • Dopamine Nation: Finding Balance in the Age of Indulgence
The big picture: While research continues, psychedelic medicine could reshape the future of healthcare and wellness. As momentum builds, scientists, startups, investors, and big pharma are plotting their next move.